David L. Brinkley, Senior VP Commercial Development at THERAVANCE INC (THRX), sold 3,623 shares at $27.67 ($100K) on 2007-09-14, disclosed to the SEC on 2007-09-14.
Scheduled sale ($100k) by Senior VP Commercial Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.51 | 100 | $3K | 2.7% |
| 2 | $27.53 | 100 | $3K | 2.7% |
| 3 | $27.54 | 100 | $3K | 2.7% |
| 4 | $27.55 | 100 | $3K | 2.7% |
| 5 | $27.56 | 200 | $6K | 5.5% |
| 6 | $27.57 | 100 |
| $3K |
| 2.8% |
| 7 | $27.58 | 100 | $3K | 2.8% |
| 8 | $27.61 | 122 | $3K | 3.4% |
| 9 | $27.63 | 100 | $3K | 2.8% |
| 10 | $27.64 | 401 | $11K | 11.1% |
| 11 | $27.65 | 100 | $3K | 2.8% |
| 12 | $27.66 | 100 | $3K | 2.8% |
| 13 | $27.67 | 300 | $8K | 8.3% |
| 14 | $27.68 | 299 | $8K | 8.3% |
| 15 | $27.69 | 101 | $3K | 2.8% |
| 16 | $27.70 | 100 | $3K | 2.8% |
| 17 | $27.72 | 200 | $6K | 5.5% |
| 18 | $27.73 | 300 | $8K | 8.3% |
| 19 | $27.75 | 100 | $3K | 2.8% |
| 20 | $27.78 | 100 | $3K | 2.8% |
| 21 | $27.79 | 500 | $14K | 13.9% |
| Total | $27.67 avg | 3,623 | $100K | 100% |
| Filing → |
| THRX | SELL | 2013-05-07 | $561K | — | Filing → |
| THRX | SELL | 2013-05-02 | $577K | — | Filing → |
| THRX | SELL | 2012-08-28 | $96K | — | Filing → |